I wouldn’t mind hearing from @Gumnut70 to give his current thoughts on DEP-Dudetaxel and the wider DEP program.
It was my contention for years that DEP-Dudetaxel was going nowhere, was likely to be a dud and would never commercialised. Gumnut70 however said I was completely clueless on the topic on a number of occasions, and he diligently and in detail explained to the forum why DEP-Dudetaxel was going to be a blockbuster and would revolutionise cancer treatment around the world. Cue a thunderous amount of thumbs up and insight bulbs.
However, subsequent to the recent underwhelming Phase 2 results (which were 5 years late), Starpharma in their webinar update have announced that DEP-Dudetaxel is being de-prioritised.
Just wondering @Gumnut70 (and others), what are your recalibrated thoughts are on the DEP program going forward.
- Forums
- ASX - By Stock
- DEP-DUDetaxel
I wouldn’t mind hearing from @Gumnut70 to give his current...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.4¢ |
Change
0.001(1.08%) |
Mkt cap ! $38.73M |
Open | High | Low | Value | Volume |
9.4¢ | 9.6¢ | 9.2¢ | $11.66K | 123.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 28393 | 9.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.6¢ | 2593 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 28393 | 0.093 |
1 | 247718 | 0.092 |
1 | 48440 | 0.091 |
2 | 80000 | 0.090 |
1 | 400000 | 0.089 |
Price($) | Vol. | No. |
---|---|---|
0.096 | 2593 | 1 |
0.098 | 19848 | 1 |
0.099 | 630 | 1 |
0.100 | 52000 | 2 |
0.105 | 92396 | 2 |
Last trade - 14.37pm 03/07/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
The Watchlist
TON
TRITON MINERALS LTD
Adrian Costello, Executive Director
Adrian Costello
Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online